oxytocin in PBS indicating that the nanoparticle may be used as an alternative brain delivery 37 system. We showed that oxytocin has sex-specific effects on social investigation, body mass, 38 sedation, and the oxytocin system. In contrast, similar effects were observed in both sexes in 39 neurogenesis and plasma 17β-estradiol. Our work suggests that sex differences in oxytocin 40 regulation of brain endpoints is region-specific (hypothalamus versus hippocampus) and 41 contributes to the evidence that oxytocin is not a prosocial hormone in both sexes. 42 Vidaña et al., 2016) . However, it is unknown whether oxytocin regulates hippocampal 66 neurogenesis in females. In females, most research has focused on the role of oxytocin in 67 anxiety-related behaviours or social behaviours related to reproduction, maternal care, and pair 68
Abstract 23
Oxytocin regulates social behaviours, pair bonding and hippocampal neurogenesis but 24 most studies have used adult males. Our study investigated the effects of oxytocin on social 25 investigation and adult hippocampal neurogenesis in male and female rats. Oxytocin has poor 26 penetration of the blood-brain barrier, therefore we tested a nanoparticle drug, TRIOZAN TM 27 (Ovensa Inc.), which permits greater blood-brain-barrier penetration. Adult male and female rats 28 were injected daily (i.p.) for 10 days with either: oxytocin in PBS (0.5 or 1.0 mg/kg), oxytocin in 29 TRIOZAN TM (0.5 or 1.0 mg/kg), or vehicle (PBS) and tested for social investigation. Oxytocin 30 decreased body mass and increased social investigation and number of oxytocin-immunoreactive 31 cells in the supraoptic nucleus (SON) of the hypothalamus in male rats only. In both sexes, 32 oxytocin decreased the number of immature neurons (doublecortin+ cells) in the ventral 33 hippocampus and reduced plasma 17β-estradiol levels in a dose-and delivery-dependent way. 34
Oxytocin in TRIOZAN TM reduced sedation observed post-injection and increased some central 35 effects (oxytocin levels in the hypothalamus and ventral hippocampus neurogenesis) relative to 36
Introduction 43
Social behaviour regulation is associated with a network that includes the prefrontal 44 cortex, medial amygdala, bed nucleus of the stria terminalis and hypothalamus (Ko, 2017) and 45 many of these areas are also connected to the hippocampus (reviewed in Jurek and Neumann, 46 2018 ). Thus, perhaps it is not surprising that the integrity of the hippocampus has been 47 Hormones, such as sex steroids and prolactin, regulate different aspects of neurogenesis, 53 proliferation, differentiation and survival of new neurons, in a sex-dependent way (reviewed in 54 Mahmoud et al., 2016) . However, much less is known about how oxytocin regulates adult 55 hippocampal neurogenesis in both sexes. 56
Oxytocin is well known for regulating social behaviours and pair bonding (Lim and 57 Young, 2006) and is mainly synthesized and secreted in the hypothalamic paraventricular 58 nucleus (PVN) and supraoptic nucleus (SON) . Surprisingly, few studies have examined roles for 59 oxytocin in both sexes even though there are sex differences in the effects of oxytocin on social 60 behavior and brain activation in both humans and animal models ( investigation, oxytocin levels in the brain and periphery, oxytocin-immunoreactive cells in the 89 hypothalamus (SON and PVN) and adult hippocampal neurogenesis in male and female rats. We 90 hypothesized that oxytocin would impact the sexes differentially and that TRIOZAN TM would 91 increase delivery of oxytocin to the brain and result in enhanced effects on social investigation 92 and hippocampal neurogenesis. 93 94
Materials and Methods 95
Animals and treatments 96
Adult male and female Sprague-Dawley rats (n=5-8/treatment/sex; 60 days old and 97 tested around 80 days old) were obtained from Charles River (Quebec, Canada) and double-98 housed with food and water available ad libitum. All protocols were approved by the 99 Institutional Animal Care Committee at the University of British Columbia and conformed to the 100 guidelines set out by the Canadian Counsel for Animal Care. Ten days after arrival, males and 101 females were randomly divided into one of the following treatment groups: oxytocin in 0.1 M 102 PBS (0.5 or 1.0 mg/kg), oxytocin delivered in TRIOZAN TM (0.5 or 1.0 mg/kg, prepared by 103 Ovensa, Inc), and vehicle control (equivalent volume of 0.1 M PBS, pH= 7.4). The volume of 104 injection was 1.0-1.2 ml for females and 1.5-2.0 ml for males. Oxytocin in TRIOZAN TM was 105 prepared using PBS and resulted in 42.2% of oxytocin bound to TRIOZAN TM . Animals received 106 daily i.p. injections for 10 days between 9:00 and 11:00. 107 108
Social Investigation 109
The three-chambered social paradigm allows for the measurement of social investigation 110 in rodents (Crawley, 2004; Ku et al., 2016; Nadler et al., 2004 ). On day 9, two hours after 111 injection, animals were allowed to explore a novel arena (100 cm x 40 cm x 40 cm) composed of 112 three connecting chambers separated by open sliding doors (Figure 3) for 10 min. Locomotion,  113 grooming, rearing, behaviours were assessed during this time to evaluate general activity. Time 114 spent in each of the chambers was also measured to ensure animals did not have a preference for 115 a particular side of the chamber. Following this habituation period, animals were briefly kept (for 116 ~2-3 min) in the central chamber with sliding doors closed while an unfamiliar and novel same 117 sex conspecific rat was placed in one of the outer chambers under a small wire cage. An identical 118 empty wire cage was secured in the other outer chamber. The unfamiliar rat was randomly 119 assigned to either the right or left side of the chamber. The test animal was then allowed to 120 explore the three chambers for a further 10 min. All sessions were recorded and scored by an 121 observer unaware of treatment conditions. Videos were scored for (1) time spent in the chamber 122 that housed the novel conspecific rat (i.e., social stimulus rat) and (2) time spent engaging in 123 investigatory behaviour with the novel rat (sniffing and touching the basket where the novel rat 124 was confined; i.e. social investigation). 125
126

Tissue and blood collection 127
Vaginal lavages were conducted on days 9 (before behaviour) and 10 (at euthanasia) to 128 account for estrous cycle phase effects on our measures. On day 10, 30 mins after receiving the 129 treatment, all rats received a lethal overdose of sodium pentobarbital. Blood was collected via 130 cardiac puncture into cold EDTA coated tubes and centrifuged 4 h later for 10 min at 4ºC. 131 0.1M PBS (4ºC) and then transferred to a 30% sucrose/0. Triton X) containing a cocktail of protease and phosphatase inhibitors using a bead disruptor 147 (Omni, VWR). Homogenates were centrifuged at 2100g for 10 min at 4ºC and supernatants 148 stored at -80ºC. Hypothalamus homogenates were run in duplicate on a modified ELISA using 149 the lysis buffer to prepare the standard curve (Enzo Life Sciences). Oxytocin levels were 150 normalized to protein content using a BCA protein assay (ThermoFisher) and expressed as 151 pg/mg protein. The oxytocin antibody is highly specific with 7.5% cross-reactivity with 152
Arginine-Vasotocin. The sensitivity of the assay is 15pg/ml and average intra-and inter-assay 153 coefficients of variation were <10%. 17β-estradiol levels were determined in plasma using a 154 commercially available radioimmunoassay kit (ultrasensitive estradiol RIA, Beckman Coulter, 155 DSL4800). All samples were run in duplicate. The assay sensitivity is 2.2pg/ml and average 156 intra-assay coefficient of variation was <20%. Samples below the zero standard curve point were 157 replaced with 0 pg/ml. gyrus at the bottom of the section was obviously present, that is between -5.2 mm to -6.7 mm 193
Bregma (Paxinos and Watson, 2005) . DCX is a microtubule-associated protein expressed in 194 proliferating progenitor cells and immature neurons, from 2 h to 3 weeks after birth in rats 195 (Brown et al., 2003) . DCX+ cells can be classified into developmental stages: proliferative (type 196 1, no or short processes present), intermediate (type 2, medium process with no branching), or 197 post-mitotic (type 3, branching dendrites; Figure 4A ). For DCX+ cell phenotyping, a total of 120 198 cells per rat were randomly selected from three different sections from dorsal (60) and ventral 199 were analyzed using ANOVA with sex (male, female) and treatment (PBS control, oxytocin in 215 PBS (0.5 or 1.0 mg/kg), oxytocin in TRIOZAN TM (0.5 or 1.0 mg/kg)) as between-subject factors. 216
Number (number of cells divided by number of sections counted) and maturity of DCX+ cells, 217
and GCL volume were each analysed using repeated measures ANOVA with hippocampal 218 region (dorsal, ventral) and an additional within-subjects factor for maturity of DCX+ cells 219 (proliferative, intermediate, post-mitotic). The data for OT-ir cells in the SON were not normal 220 or homoscedastic with female counts being more variable than male counts, even after 221 transformation. We therefore analysed males and females separately to meet ANOVA 222 assumptions. 17β-estradiol data were analysed using ANOVA separately for both sexes and 223 using estrous cycle as between-subject factors in females. We identified estrous cycle phase but 224 mass; all P's>0.15) although we observed an effect of sex (F(1,58)=120.59; P<0.0001; partial η 2 248 = 0.68; Cohen's d = 2.83) with females having significantly larger relative adrenal mass 249 compared to males. 250 251
Oxytocin causes sedation 252
Injections of oxytocin caused sedation observed 5-10 mins post-injection (Uvnäs-Moberg 253 et al., 1994). We calculated a sedation score using a binary score (0 = no sedation, 1 = sedation 254 indicated by a clear lack of locomotor activity and rearing, eyes closed and rats appearing asleep) 255 over the course of 10 days for a maximum possible score of 10. All the PBS control animals had 256 a sedation score of 0 (i.e., no sedation). In contrast, all doses and delivery methods of oxytocin 257 resulted in levels of sedation higher than 0 ( Figure 1A ). We therefore compared sedation scores 258 for the oxytocin groups only. Male rats had higher levels of sedation than female rats for the low 259 doses of oxytocin (0.5 mg/kg), regardless of delivery method (interaction between treatment and Figure 2A ). 286
Oxytocin delivered in PBS did not affect the levels of oxytocin in the hypothalamus relative to 287 the PBS controls in both sexes (P's>0.3). To investigate how peripheral and hypothalamic levels 288 of oxytocin compare between the treatment groups, we calculated the ratio of hypothalamus to 289 plasma oxytocin content. Compared to the PBS controls, all oxytocin treatments significantly 290 decreased the hypothalamus to plasma ratio in both males and females (all P's<0.001; main 291 effect of treatment F(4,36)=28.71, P<0.0001; partial η 2 = 0.76; a significant covariate effect of 292 17β-estradiol (F(1,36)=4.11, P=0.05; partial η 2 =0.10) to increase the hypothalamus to plasma 293 ratio; Figure 2B ). In addition oxytocin in PBS (1.0 mg/kg) resulted in a lower hypothalamus to 294 plasma ratio compared to the oxytocin delivered in TRIOZAN TM (1mg/kg; P<0.01; Cohen's d = 295 2.15). Using ELISA, we were not able to detect oxytocin levels in other homogenized brain 296 regions (frontal region, hippocampus). To complement the total levels of oxytocin in the 297 homogenized hypothalamus, we used immunofluorescence to investigate the effect of oxytocin 298 treatments on the number of OT-ir cells in two hypothalamic nuclei, SON and PVN ( Figure 2C Because we observed sedation shortly after oxytocin injection, we conducted social 314 investigation tests 2 hours after oxytocin injection to ensure locomotion was not affected during 315 the social investigation test. During the habituation period in the three-chambered arena, time 316 spent in locomotion was not affected by oxytocin treatment (P's>0.26; Table 2 ), but there was a 317 trend for a main effect of sex indicating that females were more active than males (F(1,58)=3.53 P=0.06 ; partial η 2 = 0.06). Oxytocin treatment did not affect the amount of time spent grooming 319 (all P's>0.41) but oxytocin in PBS (0.5 and 1.0 mg/kg) and in TRIOZAN TM (1.0 mg/kg) 320 decreased the time spent rearing during the habituation period relative to the PBS control 321 (P's=0.046, 0.018 and 0.014 respectively; Cohen's d = 0.76, 1.34 and 1.34, respectively) in 322 males and females (main effect of treatment F(4,58)=4.15; P<0.01; partial η 2 = 0.22), and 323 females reared more than males (main effect of sex F(1,58)=11.37, P<0.01; partial η 2 = 0.16; for 324 females a significant covariate effect of estrous cycle (F(1,27)=4.44, P=0.04; partial η 2 =0.14)). 325
326
Oxytocin increases social investigation in males but not females 327
During habituation, the time spent in each of the three chambers was not significantly 328 different between treatments indicating that animals did not have a preference for a particular 329 side of the chamber (all P's>0.4; data not shown). We quantified the time spent in the social 330 stimulus third of the chamber and the time investigating the social stimulus rat (i.e. sniffing and 331 touching the basket where the stimulus rat was confined) as two measures of social investigation. 332
Regardless of treatment and sex, rats spent significantly more time in the chamber with the social 333 stimulus rat compared to the empty or middle chambers (main effect of side F(2,116)=191.3, 334 P<0.0001; partial η 2 = 0.77; Table 3) . Surprisingly, none of the oxytocin treatments affected the 335 time spent in chamber with the social stimulus (P's>0.13; Figure 3B ). However, we did find 336 effects of oxytocin on time spent investigating the stimulus basket. Oxytocin in PBS (0.5 mg/kg) 337 increased the time spent investigating the stimulus basket in males (P=0.049; Cohen's d = 1.83) 338 but not female rats relative to PBS controls (P's>0.6; main effect of treatment, F(4,58)=3.67, 339 P<0.01, partial η 2 = 0.20; interaction between treatment and sex, F(4,58)=2.50, P=0.05, partial η 2 340 = 0.15; no main effect of sex, P>0.12; Figure 3C ). Social investigation of the stimulus rat was 341 not significantly different between oxytocin in PBS and oxytocin in TRIOZAN TM groups 342 (P's>0.2). 343
344
Oxytocin decreases hippocampal neurogenesis in males and females 345
The volume of the GCL was larger in males than in females (main effect of sex 346 F(1,58)=18.01, P<0.0001, partial η 2 =0.24; Table 4 ) and the volume of the ventral GCL was 347 larger than the volume of the dorsal GCL(main effect of region; F(1,58)=212.5; P<0.0001, 348 partial η 2 =0.79). Oxytocin treatments had no effect on GCL volumes (P's>0.11), therefore we in TRIOZAN TM (0.5 mg/kg) in males and females (P=0.002; Cohen's d=0.85). Males had more 359 DCX+ cells in the hippocampus than females (main effect of sex F(1,54)=9.98, P<0.01, partial 360 η 2 =0.16) and the ventral region had more DCX+ cells than the dorsal region in both sexes (main 361 effect of region F(1,54)=385.9, P<0.0001, partial η 2 =0.88). We also examined the maturity of 362 DCX+ cells in the dorsal and ventral hippocampus (Table 4 ). Oxytocin (in PBS or TRIOZAN TM ) 363 had no effect on the percentage of DCX+ cells at each stage of maturity in males and females 364 (P's>0.4). There were significantly more type 3 DCX+ cells relative to type 1 and 2 (main effect 365 of type of DCX+ cell; F(2,116)=23.09, P<0.0001; partial η 2 =0.28). Finally, we found no 366 significant correlations between neurogenesis (ventral or dorsal) and social investigation, 367 between neurogenesis and hormone levels (17β-estradiol and oxytocin) and between 368 neurogenesis and OT-ir cells in the PVN and SON. 369
370
Discussion 371
In the present study, we found that oxytocin treatment decreased body mass, increased 372 social investigation and the number of OT-ir cells in the SON in male but not female rats. In 373 contrast in both sexes, oxytocin reduced plasma 17β-estradiol levels and neurogenesis in the 374 ventral hippocampus in a dose-and delivery-dependent way. Oxytocin treatment, regardless of 375 delivery and sex, resulted in sedation effects immediately after injection. Oxytocin delivered in 376 TRIOZAN TM produced some effects that differed from oxytocin delivered in PBS. Principally, 377 oxytocin delivered in TRIOZAN TM reduced sedation and plasma oxytocin levels relative to 378 oxytocin delivered in PBS. In addition, oxytocin in TRIOZAN TM increased central measures 379 such as hypothalamic oxytocin levels and ventral neurogenesis relative to oxytocin in PBS in 380 males and females. Altogether, oxytocin resulted in sex-specific effects on social investigation 381 and OT-ir cells in the SON but similar effects between the sexes on hippocampal neurogenesis, 382 plasma 17β-estradiol and hypothalamus oxytocin levels, although some of these effects were 383 dependent on the dose and delivery system used. 384 385
Oxytocin increased social investigation in males but not females 386
In this study both males and females displayed a preference for the social stimulus in line 387 with previous research in rats (Lukas and Neumann, 2014) and mice (Crawley et al., 2007) . We 388 found that treatment with oxytocin for 10 days increased social investigation in male, but not in 389 female, rats. The finding in males is consistent with previous research in male mice and rats 390 There are very few studies doing direct comparisons between males and females, 399 nevertheless sex differences in the effects of oxytocin on neural activation have been observed in 400 humans and rodents. In humans, intranasal oxytocin resulted in sex-specific effects on brain 401 activity during reciprocated cooperation (Rilling et al., 2014) . Oxytocin increased brain activity 402 in males in areas important for reward, social bonding, arousal and memory (the striatum, basal 403 forebrain, insula, amygdala and hippocampus) whereas oxytocin had no effect or decreased this 404 response in certain areas in females (Rilling et al., 2014) . In rats, oxytocin treatment also 405 resulted in sex differences in neural activation patterns as males had more activation than 406 females in the nucleus accumbens, insular cortex, pituitary and some regions of the 407 hypothalamus whereas females had more activation in the amygdala than males (Dumais et al., 408 2017 ). In addition, males have more OTR binding sites in hypothalamic and amygdala areas 409 compared to females (DiBenedictis et al., 2017; Smith et al., 2017 ). In the current study, we 410 found that oxytocin increased the number of OT-ir cells in the SON in males only. Altogether, it 411 is possible that the lack of effect of oxytocin in females on social investigation could be related 412 to sex differences in the effects of oxytocin on OT-ir cells, OTR binding, and neural activation. Similarly, oxytocin treatment for 14 days increased DCX+ cells in adult male rats that also 425 underwent behavior (Sánchez-Vidaña et al., 2016). Altogether, this suggests that in males 426 oxytocin increases neurogenesis after prolonged treatment (14 days) or 1 to 3 weeks after 7 days 427 of treatment, however in the present study we found that oxytocin decreased neurogenesis 428 (DCX+ cells) after 10 days of exposure. Thus it is possible that in the current study we may have 429 observed an increase after more prolonged exposure to oxytocin or a longer time prior to brain 430 collection. 431
Interestingly, the effects of oxytocin on adult neurogenesis were mostly observed in the 432 ventral hippocampus, similar to previous studies in rats (Leuner et al., 2012; Opendak et al., 433 2016 In the current study, we found no significant effects of oxytocin on the proportion of cells 443 at different stages of maturation (proliferative, intermediate and mature) immediately after 10 444 days. In contrast, oxytocin treatment (1.0 mg/kg) for 14 days increased cell proliferation, number 445 of mature DCX+ cells (i.e., cells with tertiary dendrites), and dendritic complexity in the dorsal 446 hippocampus in male rats (Sánchez-Vidaña et al., 2016). In the latter study, animals were treated 447 with oxytocin for a longer period (14 days vs 10 days present study) and were subjected to a 448 battery of behavioural tests (including, forced swim test (FST)) which may have influenced the 449 results. For example, behavioural despair tests (FST) can increase oxytocin levels in the brain of 450 male rats (Yan et al., 2014) . Altogether, our work suggests that oxytocin similarly regulates 451 adult hippocampal neurogenesis in males and females but based on previous research, the effects 452 may be affected by length of exposure, neurogenesis endpoints (proliferation, maturation or 453 survival), and interaction with experiences. 454 455
Nanoparticle increases oxytocin levels in the brain and reduces oxytocin sedation side effect 456
We found that delivery of oxytocin with the nanoparticle TRIOZAN TM increased the 457 levels of oxytocin in the hypothalamus and reduced sedation and plasma oxytocin levels relative 458 to delivery with PBS. Thus, we saw oxytocin delivered in TRIOZAN TM reduced peripheral 459 effects by decreasing sedation and increased some central effects by increasing hypothalamic 460 oxytocin levels relative to oxytocin delivered in PBS. Penetration of peripheral oxytocin into the 461 brain is observed in small amounts (Neumann et al., 2013) In the current study, we observed sedation effects with both doses of oxytocin tested (0.5 468 and 1.0 mg/kg) similar to previous research showing that oxytocin causes sedation at high levels 469 (0.25 and 1.0 mg/kg) and anxiolytic effects at lower levels (<0.004 mg/kg; Uvnäs-Moberg et al., 470 1994). However, female rats receiving oxytocin delivered in TRIOZAN TM had less sedation 471 compared to oxytocin in PBS which would suggest either a slow action or release of oxytocin in 472 TRIOZAN TM or a peripheral effect of oxytocin to cause sedation. There is evidence that sleep is 473 regulated by peripheral tissues such as skeletal muscle in mice (Ehlen et al., 2017) . The 474 nanoparticle TRIOZAN TM can protect molecules from degradation (Ovensa Inc., 2018) and 475 plasma levels of oxytocin were lower in the oxytocin in TRIOZAN TM groups compared to 476 oxytocin in PBS, which may suggest that oxytocin is more actively transported to tissues 477 including the brain where it can either be stored or slowly released. 478
In our study, one limitation is that we cannot distinguish between endogenous and 479 exogenous oxytocin. One possibility is that oxytocin delivered in TRIOZAN TM increased 480 endogenous production in the hypothalamus via indirect mechanisms (e.g., through projections 481 from the periphery to the brain). Altogether, our work suggests that oxytocin in TRIOZAN TM 482 penetrated the brain but resulted in different behavioural and brain outcomes compared to 483 oxytocin in PBS. 484
485
Interactions between oxytocin and 17β-estradiol 486
In the present study, oxytocin treatment decreased plasma levels of 17β-estradiol in both 487 sexes. There is evidence that oxytocin and estrogens interact ( To our knowledge, our study is the first 492 demonstration that oxytocin regulates circulating 17β-estradiol levels indicating that the 493 interaction between these hormones is bidirectional. Our work has shown that estradiol regulates 494 many aspects of adult hippocampal neurogenesis in females (reviewed in Mahmoud et al., 2016) . 495
It is possible that the oxytocin regulation of neurogenesis is affected by endogenous levels of 496 estradiol and other sex steroids, which should be investigated. 497 498 Summary 499
We found sex differences in the oxytocin regulation of social investigation and OT-ir 500 cells in the SON of the hypothalamus. Oxytocin increased social investigation and the number of 501 OT-ir cells in the SON in males but not females. In contrast, oxytocin decreased plasma 17β-502 estradiol and neurogenesis in the hippocampus of both males and females. We also show that the 503 nanoparticle TRIOZAN TM increased oxytocin levels in the hypothalamus in males and females 504 and reduced sedation in females indicating that it can be a viable delivery system for oxytocin. 505
Our study contributes to the evidence that oxytocin is not a simple prosocial hormone in both 506 sexes. Oxytocin treatments did not affect the volume of the GCL (all P's>0.11). There were significantly more type 3 DCX+ cells relative to type 1 and 2 (main effect of type of DCX+ cell; P<0.0001). Oxytocin treatments did not affect the proportion of DCX+ cells in each stage of maturation (all P's>0.4). 
